Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma

Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma

Abstract Background Anal squamous cell carcinoma (SCC) generally carries a favorable prognosis, as most tumors are highly sensitive to standard of care chemoradiation. However, outcomes are poor for the 20–30% of patients who are refractory to this approach, and many will require additional invasive...

Full description

Bibliographic Details
Main Authors: Daniel R. Principe, Jose L. Cataneo, Kaytlin E. Timbers, Regina M. Koch, Klara Valyi-Nagy, Anders Mellgren, Ajay Rana, Gerald Gantt
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Cancer
Subjects:
Anal Cancer
Biomarkers
Chemotherapy
Radiation
Immunology
Tumor Microenvironment
Online Access:https://doi.org/10.1186/s12885-022-09742-7

Internet

https://doi.org/10.1186/s12885-022-09742-7

Similar Items